Rheumatology

• 

  Subject Areas on Research

  • "Fibrositis" syndrome. 
  • 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. 
  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. 
  • 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. 
  • 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. 
  • 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. 
  • 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. 
  • 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. 
  • 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. 
  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. 
  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. 
  • A college for its teachers. 
  • ACR Presidential Address: RethinkingRheumatology: A Brave New World. 
  • ANCA--the rheumatologist's perspective 1992. 
  • Analysis of the workforce and workplace for rheumatology and the research activities of rheumatologists early in their careers. 
  • Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). 
  • Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. 
  • Biosimilars in rheumatology: understanding the rigor of their development. 
  • Causes of creatine kinase levels greater than 1000 IU/L in patients referred to rheumatology. 
  • Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash. 
  • Choosing Wisely: the American College of Rheumatology's Top 5 for pediatric rheumatology. 
  • Classification of osteoarthritis biomarkers: a proposed approach. 
  • Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. 
  • Clinical rheumatology training of primary care physicians: the resident perspective. 
  • Clinical trials in pediatric rheumatology: comment on the editorial by Lehman. 
  • Competency-based goals, objectives, and linked evaluations for rheumatology training programs: a standardized template of learning activities from the Carolinas Fellows Collaborative. 
  • Decreasing patient cost and travel time through pediatric rheumatology telemedicine visits. 
  • Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. 
  • Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. 
  • Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group. 
  • Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11. 
  • Editorial: Shifting the Goal Posts: Treatment Recommendations for Ankylosing Spondylitis and the Newly Defined Condition of Nonradiographic Axial Spondyloarthritis. 
  • Effectiveness of rheumatoid hand surgery: contrasting perceptions of hand surgeons and rheumatologists. 
  • Enthesitis-related arthritis: time to re-define? 
  • Expert panel consensus on assessment checklists for a rheumatology objective structured clinical examination. 
  • FDDI information management system for centralizing interactive, computerized multimedia clinical experiences in pediatric rheumatology/Immunology. 
  • Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry. 
  • Fellow As Teacher Curriculum: Improving Rheumatology Fellows' Teaching Skills During Inpatient Consultation. 
  • Fibromyalgia in rheumatology practice: a survey of Canadian rheumatologists. 
  • Fibromyalgia syndrome. 
  • First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. 
  • GRAPPA 2018 Project Report. 
  • Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group. 
  • How Well Do Rheumatology Fellows Manage Acute Infusion Reactions? A Pilot Curricular Intervention. 
  • Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada. 
  • Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. 
  • Implementation and Challenges of Training Nurse Practitioners and Physician Assistants in a University Fellowship Program: Comment on the Article by Smith et al. 
  • Introducing the New Editor of Arthritis & Rheumatology, Richard J. Bucala, MD, PhD. 
  • Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis. 
  • Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. 
  • Molecular biology of nuclear autoantigens. 
  • New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA. 
  • New Roadmap for the Journey From Internist to Rheumatologist. 
  • New policy on disclosure of interest for American College of Rheumatology Journals. 
  • New policy on disclosure of interest for American College of Rheumatology journals. 
  • Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project. 
  • OMERACT endorsement of measures of outcome for studies of acute gout. 
  • OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis. 
  • Pain management in rheumatology research, training, and practice. 
  • Pediatric workforce: a look at pediatric rheumatology data from the American Board of Pediatrics. 
  • Perspectives on posttraumatic fibromyalgia: a random survey of Canadian general practitioners, orthopedists, physiatrists, and rheumatologists. 
  • Pharmacogenomics in pediatric rheumatology. 
  • Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans. 
  • Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. 
  • Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. 
  • Proceedings of the GRAPPA 2016 Retreat. 
  • Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). 
  • Recent advances in juvenile dermatomyositis. 
  • Recommendations for the Involvement of Patient Research Partners (PRP) in OMERACT Working Groups. A Report from the OMERACT 2014 Working Group on PRP. 
  • Report of the American College of Rheumatology Pain Management Task Force. 
  • Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources. 
  • Rheumatoid vasculitis: going, going, but not yet gone. 
  • Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement. 
  • Rheumatology Research Foundation Clinician Scholar Educator Award: Fifteen Years Promoting Rheumatology Educators and Education. 
  • Rheumatology in 2006: crossroads or crisis? 
  • Rheumatology in the current era: the challenge of success. 
  • Rheumatology patients' use of complementary therapies: results from a one-year longitudinal study. 
  • Standardizing clinical trials workflow representation in UML for international site comparison. 
  • Surgical management of the rheumatoid hand: consensus and controversy among rheumatologists and hand surgeons. 
  • Tackling Patient Centricity: A Report from the GRAPPA 2016 Annual Meeting. 
  • Talking with patients about alternative and complementary medicine. 
  • The 2011 ACR meeting: what's new in the Windy City. 
  • The 2013 ACR meeting: mad macs at the Marina. 
  • The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. 
  • The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. 
  • The BRIC-GARN Meeting 2011: of mice and men. 
  • The Choosing Wisely initiative: does it have your back? 
  • The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. 
  • The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. 
  • The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. 
  • The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting. 
  • The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. 
  • The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. 
  • Things do not get better by being left alone. The physician and complementary medicine. 
  • Treatment of pain in juvenile idiopathic arthritis: a survey of pediatric rheumatologists. 
  • Tuberculosis in the cytokine era: what rheumatologists need to know. 
  • Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. 
  • Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016. 
  • Validity and factor structure of the AUSCAN Osteoarthritis Hand Index in a community-based sample. 
  • Validity, factor structure, and clinical relevance of the AUSCAN Osteoarthritis Hand Index. 
  • What Is a Rheumatologist and How Do We Make One? 
  • What rheumatologists in the United States think of complementary and alternative medicine: results of a national survey.